3Bukowski RM.Natual history and therapy of metastatic renal cell carcinoma:the role of interleukin-2.Caner,1997,80:1198-1220.
4Podack EP.Execution and suicide:cytotoxic lymphocytes enforce Draconian laws through separate molecular pathways.Curr Opion Immunol,1995,7:11-19.
5Leithauser F,Dhein J,Mechtersheimer G,et al.Constitutive and induced expression of APO/1,a new member of the nerve growth factor/tumor necrosis factor receptor superfamily,in normal and neoplastic cells.Lab Invest,1993,69:415-429.
6Gratas C,Tohma Y,Barnas C,et al.Up-regulation of Fas(APO-1/CD95) ligand and down-regulation of expression in human esophageal cancer.Cancer Res,1998,58:2057-2062.
7Weller M,Malipiero U,Rensing-Ehl A,et al.Fas/APO-1 gene transfer for human malignant glioma.Cancer Res,1995,55:2936-2944.
8Sayers TJ,Brooks AD,Lee JK,et al.Molecular mechanism of immune-mediated lysis of murine renal cancer:differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.J Immunol,1998,161:3957-3965.
